Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 29 Jun 2026 for Adaptive Biotechnologies Corp. Read the official filing
Filing timeline
BuySaleMichelle Renee Griffin
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michelle Renee Griffin: trading record in brief
This profile gathers the share dealings of Michelle Renee Griffin across 2 companies, led by Adaptive Biotechnologies Corp and Chinook Therapeutics, Inc. Over a trading history stretching from 18 May 2021 to 25 June 2026, the count stands at 18 filings.
No open-market purchase appears, only 4 sales worth €442k. The totals do not cover 1 filing with an undisclosed amount. Outside the open market, there are 5 share grants and 8 option exercises. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 29 June 2026, reports an option exercise in Adaptive Biotechnologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michelle Renee Griffin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
52,084 sharesCommon StockSEC:0001229765-26-000008:0
52,084 sharesCommon StockSEC:0001229765-26-000008:1
15,394 shares@ US$13.9123.6% of flowCommon StockSEC:0001229765-26-000006:0
15,625 shares0Common StockSEC:0001229765-26-000004:0
48,044 shares@ US$3.9921.0% of flowCommon StockSEC:0001229765-26-000001:0
36,291 shares@ US$7.1939.6% of flowCommon StockSEC:0001062993-25-005644:0
15,394 shares0Common StockSEC:0001062993-25-004800:0
31,328 shares0Common StockSEC:0001062993-24-005770:0
3,300 sharesCommon StockSEC:0001209191-23-045422:0
3,300 sharesCommon StockSEC:0001209191-23-033188:0
2,341 shares@ US$8.49133.0% of flowCommon StockSEC:0001062993-23-008033:0
14,775 shares0Common StockSEC:0001062993-23-006333:0
6,689 shares0Common StockSEC:0001209191-22-005497:0
14,916 shares@ US$7.8012.7% of flowCommon StockSEC:0001209191-21-053971:0
2,500 shares@ US$7.802.1% of flowCommon StockSEC:0001209191-21-047303:0
4,000 shares@ US$7.803.4% of flowCommon StockSEC:0001209191-21-042289:0
2,500 shares@ US$7.802.1% of flowCommon StockSEC:0001209191-21-041089:0
2,500 shares@ US$7.802.0% of flowCommon StockSEC:0001209191-21-034235:0
18 of 18 declarations
